NightHawk Changes Name to Scorpius Holdings

Announces senior leadership appointments.

NightHawk Biosciences, an integrated contract development and manufacturing organization (CDMO), is changing the name of the company to Scorpius Holdings, Inc. to better reflect the company’s shift into a pure-play, large molecule biomanufacturing CDMO. The company will continue to operate its CDMO within the Scorpius BioManufacturing subsidiary.  In addition, the company promoted Brian O’Mara to vice president of process sciences and Steve Lavezoli to vice president of commercial operations....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters